MedTrace Logo

Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate

NCT01083797 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-10-25

No results posted yet for this study

Summary

This study evaluates the use of dexmedetomidine or chloral hydrate for sedation during electroencephalography in patients with neurological disorders. The hypothesis is that this drugs provides similar changes in EEG pattern.

Conditions

  • Other Conditions of Brain

Interventions

DRUG

Dexmedetomidine

1 μg kg-1 infused in 10 min, and thereafter maintained from 0.2 to 0.7 μg kg-1 h- 1

DRUG

Chloral Hydrate

Initial dose=50 mg/kg

Sponsors & Collaborators

  • Santa Casa de Misericórdia de Belo Horizonte

    collaborator OTHER

  • Federal University of Minas Gerais

    lead OTHER

Principal Investigators

  • Magda Fernandes · Santa Casa de Misericórdia de Belo Horizonte

  • Gomez Renato · Federal University of Minas Gerais

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
38 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2013-03-31
Completion
2013-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01083797 on ClinicalTrials.gov